With Market Size Valued at $2.1 Billion by 2026, it`s a Healthy Outlook for the Global Neurorehabilitation Devices Market

BY PR Newswire | ECONOMIC | 11/16/21 10:55 AM EST

SAN FRANCISCO, Nov. 16, 2021 /PRNewswire/ --?A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled?"Neurorehabilitation Devices - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

Global Neurorehabilitation Devices Market

Edition:?9;?Released:?November 2021
Executive Pool:?5339
Companies:?95 - Players covered include Bioness Inc.; Ectron Ltd.; Ekso Bionics; Helius Medical Technologies; Hocoma AG; Kinestica; Kinova Inc.; Medtronic PLC; Neurostyle Pte Ltd.; Rehab-Robotics Company Limited. and Others.
Coverage:?All major geographies and key segments
Segments:?Product (Neurorobotic Systems, Brain Computer Interface, Wearable Devices, Brain Stimulators); Application (Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Other Applications)
Geographies:?World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific ; Latin America ; Middle East ; and Africa.

Complimentary Project Preview -?This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass? Platform which offers thousands of data bytes without an obligation to purchase our report.?Preview Registry


Global Neurorehabilitation Devices Market to Reach US$2.1 Billion by the Year 2026
Neurorehabilitation devices are intended to improve function and wellbeing as well as alleviate symptoms of various nervous system disorders and trauma. Neurorehabilitation devices are used to examine the brain or central nervous system as well as deploy specific electric signals to fibers of spinal cord to recover limb movements. These devices encompass non-invasive brain stimulators, wearable devices, brain-computer interfaces and neuro-robotic systems. Intended to mitigate symptoms and improve neurological function, these devices are commonly used in physiotherapy and improve quality of life of patients. Growth in the global market is set to be fueled by high incidence of neurological conditions, rising geriatric population and technological advances. The market is anticipated to gain from increasing influx of new companies with innovative devices and better access to healthcare services. Neurorehabilitation devices are witnessing extensive use in clinical settings, cognitive care, healthcare centers and research institutes. The combination of rapidly advancing robotics technology and neuroscience is leading to the development and availability of next-generation rehabilitation techniques. The market expansion is also favored by consistent focus of companies on technological advances to come up with innovative devices capable of offering better therapeutic options for neurological conditions and improving patient outcomes.

Amid the COVID-19 crisis, the global market for Neurorehabilitation Devices estimated at US$932.7 Million in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2026, growing at a CAGR of 14.8% over the analysis period. Neurorobotic Systems, one of the segments analyzed in the report, is projected to grow at a 17.1% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Brain Computer Interface segment is readjusted to a revised 11.1% CAGR for the next 7-year period. This segment currently accounts for a 25% share of the global Neurorehabilitation Devices market. Neurorobotic devices refer to a new method that combines neuroscience, rehabilitation and robotics to treat neurological disorders, and the method used for treatment often depends on the specific function that needs to be restored. Currently, robotic intervention is gaining popularity with expanding applications of mobility restoration in patients with spine and neurological disorders, brain trauma, spinal injuries, cerebral palsy, and several other conditions. Neural interfaces or brain-machine interfaces represent a relatively new system for neurorehabilitation that is finding increased use in clinical applications. These systems facilitate communication between a patient's brain and an external device.

The U.S. Market is Estimated at $383 Million in 2021, While China is Forecast to Reach $270.3 Million by 2026
The Neurorehabilitation Devices market in the U.S. is estimated at US$383 Million in the year 2021. The country currently accounts for a 38.5% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$270.3 Million in the year 2026 trailing a CAGR of 21.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 14.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR while Rest of European market (as defined in the study) will reach US$331.3 Million by the end of the analysis period. North America retains dominant position on account of rising cases of neurological disorders, increasing aging population and technological advancements. The market growth is facilitated by rising awareness about advantages of neurorehabilitation devices coupled with presence of a robust healthcare infrastructure. Europe is another key market and growth is attributable to rising cases of neurological disorders and availability of numerous approved devices. Growth in Asia-Pacific region is being driven by increasing incident of neurological disorders, rising geriatric population and strong demand for advanced neurorehabilitation devices.

Wearable Devices Segment to Reach $454.6 Million by 2026
The neurorehabilitation wearable devices segment is poised to maintain its positive trajectory due to availability of innovative options offering better alternatives to traditional neurorehabilitation approaches. Increasing cases of stroke in the US and other countries are poised to push uptake of wearable neurorehabilitation devices through all phases of the treatment process. In the global Wearable Devices segment, USA, Canada, Japan, China and Europe will drive the 15.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$166.6 Million in the year 2020 will reach a projected size of US$455.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$28.6 Million by the year 2026, while Latin America will expand at a 17.9% CAGR through the analysis period. More

MarketGlass? Platform
Our MarketGlass? Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on?iOS?or?Android

About Global Industry Analysts, Inc. & StrategyR?
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: ZA@StrategyR.com

Join Our Expert Panel

Connect With Us on LinkedIn

Follow Us on Twitter

Journalists & Media

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/with-market-size-valued-at-2-1-billion-by-2026--its-a-healthy-outlook-for-the-global-neurorehabilitation-devices-market-301423834.html

SOURCE Global Industry Analysts, Inc.

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.